Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04092270
Title A Study Combining the M3814 Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Patients
Recruitment Suspended
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

ovarian serous carcinoma

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer

Therapies

MSC2490484A + Pegylated liposomal-doxorubicin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.